News
22h
GlobalData on MSNEC approves Jazz Pharmaceuticals’ Ziihera for biliary tract cancerJazz Pharmaceuticals has received conditional marketing authorisation from the European Commission (EC) for its new ...
US biotech Jazz Pharmaceuticals yesterday announced that the European Commission (EC) has granted conditional marketing ...
Focus on incorporating these key foods into your diet to ‘transform your health from the inside out’ and combat fatty liver ...
16h
Verywell Health on MSN5 Serious Ozempic Side Effects Most People Do Not Know AboutOzempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...
17h
Belfast News Letter on MSNCancer in Northern Ireland: Incidence rises, survival ImprovesQueen’s University Belfast’s Northern Ireland Cancer Registry (NICR) has published comprehensive data on cancer in Northern ...
Mayo Clinic says that Lynch syndrome is caused by genes that are passed from parents to their children. I’ll let them explain: “Genes are pieces of DNA. DNA is like a set of instructions for every ...
US FDA clears Iksuda Therapeutics’ IND application for IKS014: New Castle, England Wednesday, July 2, 2025, 15:00 Hrs [IST] Iksuda Therapeutics, a clinical stage and UK-based bi ...
A quack is a “fraudulent or ignorant pretender to medical skill” or “a person who pretends, professionally or publicly, to have skill, knowledge, qualification or credentials they do not possess. MD B ...
Topline data were announced from a phase 3 trial evaluating bemarituzumab plus chemotherapy in individuals with gastric or gastroesophageal junction cancer with FGFR2b overexpression.
Gallstone disease is linked to metabolic disorders, such as obesity, diabetes, and metabolic dysfunction-associated steatotic liver disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results